Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Immix Biopharma | IMMX | Nov 25, 2024 | 1.72 | -3.91 |
ImmuCell | ICCC | Nov 25, 2024 | 3.74 | +1.36 |
Immuneering A | IMRX | Nov 25, 2024 | 2.08 | -0.95 |
Immunic | IMUX | Nov 25, 2024 | 1.18 | +7.27 |
ImmunityBio | IBRX | Nov 25, 2024 | 5.04 | -1.18 |
Immunocore ADR | IMCR | Nov 25, 2024 | 32.79 | +1.58 |
Immunome | IMNM | Nov 25, 2024 | 11.15 | +13.54 |
ImmunoPrecise Antibodies | IPA | Nov 25, 2024 | 0.38 | +1.60 |
Immunovant | IMVT | Nov 25, 2024 | 26.89 | +0.07 |
Immutep ADR | IMMP | Nov 25, 2024 | 2.02 | +4.94 |
Imperial Oil | IMO | Nov 25, 2024 | 75.68 | -1.88 |
Imperial Petroleum | IMPP | Nov 25, 2024 | 3.29 | -2.37 |
Imperial Petroleum A Pref | IMPPP | Nov 25, 2024 | 25.30 | 0.00 |
Impinj | PI | Nov 25, 2024 | 193.63 | +1.36 |
Imunon | IMNN | Nov 25, 2024 | 0.81 | +0.14 |
IN8bio | INAB | Nov 25, 2024 | 0.30 | -4.35 |
Inari Medical | NARI | Nov 25, 2024 | 49.48 | -0.36 |
Incannex Healthcare ADR | IXHL | Nov 25, 2024 | 1.98 | -0.27 |
Inception Growth Acquisition | IGTA | Nov 25, 2024 | 11.72 | -0.26 |
Inception Growth Acquisition Unit | IGTAU | Nov 25, 2024 | 11.60 | 0.00 |
Income Opportunity Realty Investors | IOR | Nov 25, 2024 | 16.01 | 0.00 |
Incyte | INCY | Nov 25, 2024 | 73.52 | +2.51 |
Indaptus Therapeutics | INDP | Nov 25, 2024 | 1.03 | +3.00 |
Independence Realty Trust | IRT | Nov 25, 2024 | 21.74 | -0.05 |
Independent Bank | INDB | Nov 25, 2024 | 74.97 | +1.34 |
Independent Bank | IBCP | Nov 25, 2024 | 38.87 | +0.96 |
Independent Bank Group | IBTX | Nov 25, 2024 | 67.31 | +2.78 |
India Bull 3X Direxion | INDL | Nov 25, 2024 | 65.45 | +2.27 |
India Consumer Egshares | INCO | Nov 25, 2024 | 68.44 | +0.77 |
India Earnings Wisdomtree | EPI | Nov 25, 2024 | 47.29 | +1.46 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.